Evidence-based Approaches to Gradual Dose Reductions of Antipsychotic Drugs
The use of antipsychotic drugs for the management of the Behavioral and Psychological Symptoms of Dementia (BPSD) is not an FDA-approved indication, is controversial, and yet continues to be [...]